Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunostimulating Nutrition in Upper GI Surgery
NCT00558155Phase 4Completed
- Sponsor
- Jagiellonian University
- Start
- Jun 2001
- Modality
- Lipid-based Nanoparticles, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid, alanyl glutamine, buspirone in gastric cancer (GC), pancreatic cancer (PC), sponsored by Jagiellonian University. Started Jun 2001; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acidalanyl glutaminebuspirone
03
Conditions
gastric cancer (GC)pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00558155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558155.